ClinDev

Analysis, Insight & Engagement for Clinical Development

Skip to content
  • Home
  • Latest news
  • Features
    • Interviews
    • Humour
  • Calendar
  • Jobs
  • Contact/Advertise
    • Donate
    • CV
ClinDev

Latest items

  • US government outlines “Precision Medicine” plans
  • ICON creates new innovation hub in Ireland
  • Chugai to launch translational research division
  • FDA announces intended guidance topics for 2015
  • CHMP recommends medicines be suspended after CRO inspection
  • EMA launches consultation on transparency & Clinical Trials Regulation
  • Clinipace set for new wave of CRO M&A activity
  • Report highlights rising levels of investigator turnover & protocol noncompliance
  • US Institute of Medicine backs clinical data transparency
  • EMA clinical data publication policy comes into force

Most read

  • Spanish investigator conducted clinical trial without regulatory or ethics approval
  • …
  • Janet Messer - Changes in R&D approval
  • ICR GCP & Ethics Forum wrap-up
  • AstraZeneca to partner with Cambridge cancer centres
  • Study reveals improvements in public perceptions of clinical research
  • First clinical trial using iPS cells cleared in Japan
  • UK government to expand Office for Life Sciences
  • AstraZeneca to buy out BMS from diabetes joint venture

Browse by topic

  • AbbVie
  • AstraZeneca
  • Clinical trial data
  • Conference
  • corporate
  • CRO
  • data protection
  • Declaration of Helsinki
  • eclinical
  • EFPIA
  • EMA
  • Ethics
  • Europe
  • FDA
  • GSK
  • Guidance
  • Health Research Authority
  • ICR Forum
  • India
  • informed consent
  • Intellectual property
  • IPO
  • M&A
  • MAA applications
  • MHRA
  • NHS
  • NIHR
  • Novartis
  • Oncology
  • Partnership
  • Patient recruitment
  • pharmacovigilance
  • Quintiles
  • R&D
  • Regulation
  • Research ethics
  • Risk-adaptive monitoring
  • Risk-based approach
  • Roche
  • Select committee
  • Survey
  • transparency
  • UK
  • USA
  • webinar
Proudly powered by WordPress